• Cerebral autoregulation was studied in the baboon by increasing and decreasing cerebral perfusion pressure (CPP) before and after intravenous administration (1..5 mg per kilogram) of a long-acting alpha adrenergic blocker, phenoxybenzamine (PBZ). Likewise, cerebral vasomotor reactivity to changes of arterial carbon dioxide tension (Paco 2 ) was examined before and after PBZ.
• Cerebral autoregulation was studied in the baboon by increasing and decreasing cerebral perfusion pressure (CPP) before and after intravenous administration (1..5 mg per kilogram) of a long-acting alpha adrenergic blocker, phenoxybenzamine (PBZ). Likewise, cerebral vasomotor reactivity to changes of arterial carbon dioxide tension (Paco 2 ) was examined before and after PBZ.
In order to permit quantitative analysis, cerebral autoregulation (A.I.) and chemical vasomotor reactivity (C.I.) were expressed as indices where " • " ACPP " ' " ""*• APaco 2 ' Following the intravenous injection of PBZ, cerebral auioregulatory vasoconstriction was impaired as CPP was increased. Cerebral vasomotor reactivity to changes in Paco 2 was altered both during hyperventilation hypocapnia (HV) and hypercarbia induced by inhalation of 5% carbon dioxide if alterations of CPP brought about by these procedures were taken into consideration. During hypocapnia C.I. was reduced 30% and during hypercarbia C.I. was increased 10%.
It is concluded that PBZ reduces the vasoconstrictor tonus of cerebral vessels during hypocapnia and raised CPP. It also enhances the vasodilator response to CO, inhalation. Besides myogenic and metabolic control, recent data suggest that there are neurogenic influences in controlling CBF but it is not clear what part neurogenic influences may play in autoregulatory (myogenic) or chemical (metabolic) control of CBF. Current theories raise for consideration whether or not neurogenic in-fluences may play any part in cerebral autoregulation (i.e., the ability of the brain to retain its blood flow constant despite changes in perfusion pressure). 914 Another question to be considered is whether neurogenic influences play any part in chemical control (i.e., the ability of the brain to alter its blood flow to supply its metabolic needs), particularly in response to changes in arterial carbon dioxide tension 3 - 1 4 Histological evidence for the innervation of cerebral vessels is now well established. 15 Histochemical and electron microscopic studies 16 " 20 have shown a dual adrenergic and cholinergic innervation of cerebral vessels down to 15 n in size.
Additional Key Words
Measurements of cerebral circulation in many laboratories gave evidence that CBF was altered by stimulation of the cervical sympathetic nerves, 2127 by vagal stimulation or section, 23 by stimulation of brain stem centers 2831 or by administration of epinephrine, norepinephrine or agents causing blockade or pharmacological stimulation of the cerebral vascular innervation. 3235 James et al. 23 reported that section or stimulation of the cervical sympathetic nerves during manipulation of Pacos or cerebral perfusion pressure (CPP) altered cerebrovascular responses to changes in PacO2 and to autoregulation. Their data suggested that the cerebrovascular reactivity to sympathetic influences may be CO 2 dependent. Later, Harper et al. 22 showed that sympathetic stimulation of the cephalic end of the cervical chain after sympathectomy causes a 25% reduction of the elevated CBF induced by hypercapnia.
Clinical studies showed that there was a dissociation of cerebral vasomotor responses to changes in CPP and Pacoa in certain patients with Shy-Drager syndrome and cerebral infarction. 10 ' 12> 3Bi 37 It has also been shown by administration of catecholamines or adrenergic blocking agents that adrenergic receptors function in cerebral vessels. For example, reduction of CBF caused by drug-induced spasm or that due to subarachnoid hemorrhage may be relieved by alpha receptor blockers. Likewise, it has been suggested that cerebral hypocapnic vasoconstriction is diminished by alpha adrenergic blockade and autoregulation may be subtly modified. The present study was therefore undertaken in normal, healthy baboons in order to evaluate whether long-acting alpha adrenergic blockade by phenoxybenzamine (PBZ) altered cerebral autoregulation and chemical regulation of CBF.
Methods
Ten baboons (Papio anubis) weighing 4 to 9 kg were anesthetized with intravenous pentobarbital 30 mg per kilogram body weight. Pentobarbital was supplemented as required to maintain light anesthesia. After tracheostomy gallamine triethiodide (Flaxedil®) was administered in doses of 10 mg per kilogram body weight and respiration was maintained constant with a Harvard variable speed respirator adjusted to maintain PacQa between 30 and 38 mm Hg. End-tidal CO 2 was recorded with a Beckman infrared gas analyzer.
Catheters were inserted through the femoral artery into the descending aorta to monitor systemic blood pressure and into both femoral veins to permit intravenous injections and to return blood from a small extracorporeal cuvette system for monitoring arterial and cerebral venous blood gases and pH. The neck was dissected and both external carotid arteries, external jugular veins, vertebral veins and tributaries of internal jugular veins were ligated. After isolation of both carotid arteries, internal jugular veins, sympathetic and vagus nerves, circulation to the remaining cervical muscles was interrupted by a tight ligature drawn around the neck. The vagus nerves and cervical sympathetic chains were meticulously preserved intact during these surgical procedures so that pupillary responses and cardiovascular activity were not altered after surgical preparation. Electromagnetic flowmeters were placed around both internal jugular veins and CBF was measured as cerebral venous outflow. 40 The procedure for continuous monitoring of CBF is in good agreement with concurrent measurements of CBF using the nitrous oxide method, and contamination of CBF by extracerebral blood is minimal. 41 For blood gas analysis, cerebral venous blood was withdrawn from a catheter placed into the torcular Herophili via the extracorporeal system. A separate catheter was wedged into the anterior part of the superior sagittal sinus to measure intracranial venous pressure which did not significantly alter CBF. After heparinization of the animal by intravenous injection of 1,000 IU heparin per kilogram body weight, cerebral venous oxygen tension (PVO 2 ), arterial and cerebral venous carbon dioxide tension (Paco 2 , PVCO 2 ) and arterial pH (apH) were monitored continuously using the extracorporeal circulation system. 42 Cerebral arteriovenous (A-V) oxygen differences were measured with the Guyton analyzer. 43 The electroencephalogram (EEG) and electrocardiogram were also monitored.
Cerebral metabolic rate for oxygen (CMRO 2 ) was calculated as the product of CBF and A-V oxygen difference. CPP was estimated by subtracting intracranial venous pressure from mean arterial blood pressure (MABP). Cerebral vascular resistance (CVR) was calculated using the formula: CVR = CPP/CBF.
To test the autoregulatory response, an increase in MABP of 20 to 40 mm Hg was induced by inflating a balloon that had been inserted through the femoral artery into the lumen of the descending aorta. Measurements were carried out for five minutes while the CPP was increased and were repeated after the balloon was deflated at which time CPP became considerably decreased. If there was any change of Paco 2 following inflation or deflation of the balloon, CBF was corrected according to the chemical index previously determined for the baboon. 44 The autoregulation index (A.I.) was measured successfully in nine animals.
To test chemical vasomotor reactivity to changes in PacQa, a mixture of 5% CO 2 in air was inhaled through the respirator for five minutes. This increased Paco 2 to a maximum of 56 mm Hg. When the steady state level had been regained, hyperventilation was induced by increasing the speed of the respirator until Paco2 was decreased by at where A signifies change in CBF, CPP or Paco, respectively between the steady state and test conditions. The closer to zero A.I. is maintained, the more normal is the autoregulatory response. PBZ (Dibenzyline®) was injected intravenously in a concentration of 1 mg per milliliter saline by an infusion pump at the rate of 1 ml per minute until 1.5 mg per kilogram had been administered. After injection of PBZ, approximately 30 minutes were "allowed to obtain a new steady state. Justification for this time lapse to attain alpha adrenergic blockade was obtained by the hypotensive effect regularly observed following administration of PBZ. The fall in blood pressure occasioned by the PBZ was corrected to the steady state level by intravenous infusion of saline or partial inflation of the aortic balloon.
Inhalation of 5% CO 2 , hyperventilation and the tests of autoregulation were performed before and after administration of PBZ. Fifteen minutes were always allowed to attain a new steady state after each procedure. Statistical analysis of data was obtained by the use of the paired t-test. Differences having a possible error of less than 5% were considered significant.
Results

EFFECTS OF PHENOXYBENZAMINE ON CEREBRAL BLOOD FLOW
Intravenous infusion of PBZ caused an increase of CBF (17.7%) five minutes after the infusion of PBZ was completed (table 1). The increase of CBF started within one minute of infusion of PBZ, reached maximum values and gradually declined so that after 30 minutes the CBF increase was only 8%. The increased CBF occurred despite reduction of the MABP by 18% five minutes after the infusion and 27% 30 minutes after the PBZ infusion. CVR decreased after PBZ infusion. Correlation of the time course of the CVR decrease with the fall of MABP indicates that the decrease of CVR was due not only to the fall of MABP but also to a vasodilator effect of PBZ. CMRO 2 showed no significant change 30 minutes after PBZ injection at which time the tests of autoregulation and chemical regulation were made. The hypotension was taken as evidence of the effectiveness of the dose. EEG and EKG showed no change.
EFFECTS OF PHENOXYBENZAMINE ON CEREBRAL AUTOREGULATION
Changes of CBF and hemodynamics at five-minute intervals during tests of autoregulation with hypertension and hypotension are displayed in figure 1 after correction for any changes in Paccv Measurements where the blood pressure decreased below MABP of 70 mm Hg were excluded from analysis since autoregulation has been reported to be impaired when MABP decreases below 70 mm Hg. Autoregulation and other parameters were computed at intervals of one minute after manipulating the blood pressure with the aortic balloon.
When CPP was increased suddenly, CBF increased transiently but then decreased progressively despite the fact that CPP remained constant, e.g., the classic autoregulation response with a progressive increase in CVR (figs. 2 and 3).
Before PBZ was administered, cerebral autoregulation was considered to be within normal limits in all nine animals. Mean CBF increased from 39 to 46 ml/100 gm brain per minute within the first minute of raising the MABP by 20 mm Hg, but within five minutes had returned to 39 ml/100 gm brain per minute. This is the normal pattern of autoregulation which has a fast and slow component. 46 The A.I. decreased from 0.37 within the first minute to 0.004 within five minutes. The difference between these two A.I. values during induced hypertension prior to PBZ was statistically significant at the P < 0.001 level of confidence. The increase in CVR during induced hypertension was also highly significant.
When the blood pressure was decreased there was a rapid decrease of mean CPP by 29 mm Hg after one minute and 21 mm Hg at the end of five minutes. Mean CBF decreased immediately by 7 ml/100 gm brain per minute and thereafter progressively increased back to 36 ml/100 gm brain per minute at the end of five minutes. The improvement in the A.I. from the first to the fifth minute was highly significant Mean ± standard error.
• = Statistical significance (P < 0.05). CBF = cerebral blood flow, CVR = cerebral vascular resistance, Paco 2 = arterial carbon dioxide tension, MABP = mean arterial blood pressure, CMRO 2 = cerebral oxygen consumption. 
Typical recording during testing of cerebral autoregulation. Left panel was recorded before PBZ infusion. Internal jugular flow (UFj decreased rapidly at first and then more slowly until five minutes after induced hypertension. CBF then reached steady state levels, indicating normal autoregulation. Right panel was recorded after five minutes of induced hypertension, indicating impaired autoregulation.
(P < 0.005). Likewise, the decrease in mean CVR was highly significant (P < 0.005). After PBZ infusion the mean increase in CPP during A.I. testing was 25 mm Hg. CBF increased from 45.0 to 54.5 ml/100 gm brain per minute in the first minute and thereafter remained virtually constant (i.e., autoregulation was abolished) over the next five minutes so that at this point it was 54.4 ml/100 gm brain per minute. After PBZ, A.I. showed no significant change from the first to the fifth minute. Furthermore, comparison of A.I. values at each minute interval before and after PBZ infusion showed that in every case A.I. was higher (table 2) .
On the other hand, injection of PBZ did not appear to alter autoregulation when BP was lowered. When CPP was decreased by 43 mm Hg there was a rapid reduction of CBF by 10 ml/100 gm brain per minute and thereafter CBF increased to 46 ml/100 gm brain per minute after five minutes. Likewise, A.I. improved from the first to the fifth minute. In summary, intravenous injection of PBZ impaired cerebral autoregulation when CPP was raised, but did not alter cerebral autoregulation when CPP was lowered. These results indicate that cerebral vasoconstrictive autoregulation is influenced by alpha adrenergic innervation.
EFFECTS OF PHENOXYBENZAMINE ON CEREBRAL CHEMICAL VASOMOTOR REACTIVITY
Before infusion of PBZ, inhalation of 5% CO 2 increased CBF significantly by 57 ml/100 gm brain per minute as Pacc^ rose by 16 mm Hg. Intracranial venous pressure likewise increased by 36 mm Hg during CO 2 inhalation so that CPP was significantly decreased. CVR significantly decreased by 73%. Prior to PBZ administration the C.I. was 3.52 (table 3A) .
After infusion of PBZ, CBF was significantly increased by administration of the drug itself and was greatly increased by 60 ml/100 gm brain per minute after five minutes of CO 2 inhalation when Paco2 had increased by 17 mm Hg and CPP had decreased by 28 mm Hg and intracranial venous pressure had increased by 58%. CVR also decreased. The C.I. was not significantly changed before and after PBZ administration. Although vasodilatation occurred by inhalation of 5% CO 2 before and after PBZ, the changes of CPP must be taken into account since they were different between the two states. CPP was reduced due to a concomitant increase in intracranial venous pressure during inhalation of 5% CO 2 and this was greater after PBZ; hence some adjustment in CBF values corresponding to the differences in CPP is necessary in order to estimate the pure vasodilatory effect of CO 2 . To accomplish this, CBF was corrected to the steady state value for CPP by using a formula already determined in the baboon. 44 This formula permits calculation of the expected change in CVR when the perfusion pressure is altered. The formula may be stated as: AF = AP ACVR where AF = the change in CBF and AP = ACPP (calculated from MABPsagittal sinus wedge pressure) between the steady state levels and the level after changing the perfusion pressure. By utilizing this correction, at the end of five minutes after inhalation of 5% CO 2 CBF had increased to 105 ml/100 gm brain per minute before PBZ and 127 after PBZ. The corrected chemical indices were 4.2 before PBZ and 4.7 after PBZ, which was a significant difference (P < 0.05) indicating a greater vasodilatation induced by CO 2 inhalation after PBZ (table 3B) . Reactivity to decrease in Pacc^ was tested by hyperventilation in eight animals. Before infusion of PBZ, CBF was significantly decreased during hyperventilation of ambient air by 7.2 ml/100 gm brain per minute at the end of five minutes. During hyperventilation hypocapnia (HV) the PacQz was reduced by 7.5 mm Hg. CPP did not change significantly but CVR increased by 27%. The change in CBF, calculated as the C.I., was 0.98 (table 4) .
After infusion of PBZ, CBF decreased during HV for five minutes by 5.9 ml/100 gm brain per minute when Pacos was reduced by 8 mm Hg. Differences between changes of flow obtained before and after PBZ infusion were not statistically significant. CPP remained unchanged.
CVR increased to a less significant degree when HV was carried out after PBZ infusion than before, indicating the ability of cerebral vessels to constrict. However, the uncorrected values for C.I. during hyperventilation were not statistically different before and after PBZ.
In the above calculations no correction was made for changes of perfusion pressure during HV based on previous experiences in baboons 44 this correction are displayed in table 3B and figure 4. The adjusted decrease of CBF at the end of hyperventilation for five minutes in the PBZ-treated animals was 5.4 ml, a statistically significant reduction in vasoconstrictor response compared to the steady state. Likewise, the adjusted C.I. was reduced by PBZ during HV. As might be expected, there was also a highly significant decrease in adjusted CVR during HV after PBZ. Taken together, these data indicate that intravenous injection of PBZ enhanced vasodilator tonus and decreased vasoconstrictor tonus during tests of both autoregulation and chemical vasomotor responsiveness to changes in Pacc^.
Discussion
With the aid of these new observations let us now consider the several hypotheses concerned with mechanisms of cerebral autoregulation and chemical vasomotor responsiveness to alterations in Pacos. These various theories are by no means mutually exclusive and more than one may prevail. The initial theory was the myogenic hypothesis 14 which proposed that an intrinsic mechanism exists in the smooth muscle cells of cerebral arteries or arterioles which responds to an increase in internal pressure by contracting and to a decrease in pressure by dilating (as in the majority of hollow viscera throughout the body).
The second hypothesis was that the level of H + ion of brain tissue, either within the intracellular space of smooth muscle cells or in the extracellular space bathing the smooth muscle cells, alters the tonus of the smooth muscle cell in such a manner as to maintain constant CBF and thereby becomes the most important controlling factor in both autoregulation and chemical vasomotor control. 5 ' 8 ' 46 Finally, a third hypothesis considered both a direct chemical action of pH change on vasomotor tone plus a neurogenic influence mediated by changes in CO 2 and pH, acting via the brain stem and influencing neurogenic vasomotor tone. James et al. 23 were among the first to report altered chemical vasomotor responses to changes in Paco2 as well as the autoregulatory control after section or stimulation of the cervical sympathetic or parasympathetic nerves, and postulated that the sympathetic system modulated cerebral vasomotor responsiveness to changes in Paccv Others established that cerebral vasoconstriction following subarachnoid hemorrhage or mechanical stimulation was associated with a local release of catecholamines. pathetic discharges affecting the cerebral vessels, however, may only be part of a general systemic autonomic discharge. 54 The role of the autonomic nervous system in cerebral autoregulation in man was demonstrated in patients with idiopathic orthostatic hypotension (ShyDrager syndrome). 10 ' 36 These patients showed loss of autoregulation with apparent preservation of chemical vasomotor responsiveness.
The present experiments have tested the hypothesis that the sympathetic nerves tested may influence cerebral vascular tonus and hence play a role in modulating chemical vasomotor activity if concurrent changes in CPP are considered. The initial quick phase of autoregulation has been described as the rapid response and was thought to be due to both myogenic reflex and sympathetic control by Yoshida et al. 45 since it was impaired after cervical sympathectomy.
In the present experiments the greatest alteration by PBZ infusion was in the rapid response of autoregulation, since 30 seconds after CPP was raised the A.I. was 0.369 before PBZ injection and 0.407 after the infusion. This observation lends support to the view of Yoshida et al. 45 that the "rapid response" of autoregulation is both myogenic and neurogenic in nature while the later response may be mediated by other factors such as chemical regulation. Symon et al. 4 concluded that the fast component termed the "rapid response" may well be explicable by a myogenic reflex alone; the present results and those of Yoshida et al. 45 indicate that the sympathetic nervous system exerts an important regulatory control over this myogenic response. Furthermore, the present data show that autoregulation was complete within five minutes, but after PBZ infusion autoregulation remained impaired after five minutes of sustained increase of perfusion pressure. Indeed, comparison of A.I. values before and after PBZ infusion at intervals of one minute after CPP was raised showed significant differences after three minutes so that both the rapid and delayed phases of autoregulation were impaired. The delayed phase or progressive autoregulation has been considered solely metabolic, 4 ' 5 -tb but the present data suggest that this, too, may have been neurogenic, especially adrenergic regulation. In these experiments autoregulatory response when CPP was decreased was not affected by PBZ injection, indicating alpha adrenergic innervation is more concerned with vasoconstrictor tonus as reported in man. 37 The present data are in agreement with those reported in man 37 ' 55 and with the view that when CPP is raised, autoregulation is mainly mediated by the alpha adrenergic innervation of cerebral arteries. 56 Let us now consider the possible physiology of the adrenergic neurogenic control of cerebral vessels.
PBZ, CEREBRAL AUTOREGULATION AND CO, RESPONSES
Kanzow and Dieckhoff," Rosenblum, 54 Rosenblum and Guilianti 68 and Kobayashi et al. 24 independently argued that the most important regulatory activity must occur at the precapillary arterioles of approximately 10 to 30 n in diameter and that changes in the caliber of larger arterioles would exert a definite but less important influence on CBF. Direct observation of the pial arteries having a diameter of less than 50 n did indeed show the expected increases of diameter during CO 2 inhalation and decreases during hyperventilation (chemical regulation). On the other hand, arteries with a diameter of more than 50 n showed the most pronounced changes during alterations of CPP, 56 namely, a decrease in diameter when CPP was raised and an increase in diameter when CPP was lowered (autoregulation). This physiological effect is entirely compatible with the anatomical distribution of the autonomic innervation and with the concept of a dual regulatory mechanism controlling CVR, 3S the one being a neurogenic control influencing the caliber of the larger cerebral vessels and the other being primarily chemically controlled and involved the small parenchymatous arteries of 10 to 30 ix in diameter.
Fraser et al. 38 and Corbett et al. 34 demonstrated separately that either of the two alpha adrenergic blocking agents, PBZ or thymoxamine, depressed the hypocapnic vasoconstrictor effect. When correction was made for associated changes in blood pressure and CPP, the present data are in agreement with theirs. It is believed that such correction is warranted because the dual mechanisms regulating vascular resistance within the larger extraparenchymatous vessels (neurogenic) and the small intraparenchymatous vessels may sometimes compete in an opposite direction. Let us first consider the effect of CO 2 inhalation and PBZ administration on both these controlling systems. It has been shown that the small intraparenchymatous vessels dilate (chemical control) while the larger extraparenchymatous vessels constrict 56 as the CPP increases due to the hypertension induced by CO 2 inhalation (autoregulatory control). When PBZ is administered the alpha adrenergic constrictor tonus is reduced and blood pressure decreases and the cerebral extraparenchymatous vessels dilate. After PBZ administration CO 2 inhalation causes an apparently excessive increase of ACBF, since the extraparenchymatous vessels larger than 50 j u now have unopposed beta adrenergic and cholinergic vasodilator effects and hence respond excessively to changes in Pacoj while the pial vessels have little sympathetic response. 59 In conclusion, cerebral autoregulation, particularly when CPP is increased, appears to be influenced by alpha adrenergic innervation which increases cerebral vasomotor tonus. Evidence is offered that chemical regulation is influenced likewise but to a lesser degree. This was revealed in the present study by adjusting for concomitant changes in CPP during changes in Paccv
